Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bepotastine vs Olopatadine in Allergic Conjunctivitis
NCT04776096Phase 4Completed
- Sponsor
- Laboratorios Poen
- Start
- Mar 2021
- Primary completion
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of bepotastine in allergic conjunctivitis (AC), sponsored by Laboratorios Poen. Started Mar 2021; status: completed.
02
Drugs
bepotastine
03
Conditions
allergic conjunctivitis (AC)
Beyond the preview
Go deeper on NCT04776096.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04776096.